VivArt-X B.V is a startup based in the Netherlands, most recent round Seed, 2 tracked investors.
VivArt-X B.V is a company founded in 2026 headquartered in the Netherlands. Its most recent tracked round is Seed. Brouky records 2 investors associated with the company.
VivArt-X develops synthetic, degradable biomaterials for personalized breast reconstruction in women who have undergone breast tissue removal due to cancer, supporting cell engraftment and regeneration.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.